PILA PHARMA AB
Clinical stage biotech developing an oral obesity and diabetes treatment.
Oversikt
- 1–4
- Ansatte
- 750–999t SEK
- Omsetning
- 2014
- Grunnlagt
Beskrivelse
PILA PHARMA is a clinical stage biotechnology company focused on innovative drug development. The organization is pioneering the development of XEN-D0501, an oral TRPV1-antagonist. This drug candidate is being positioned as a potential first-in-class treatment for serious conditions like obesity and...